(Q40621328)
Statements
1 reference
Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response (English)
1 reference
Gollob JA
1 reference
Mier JW
1 reference
Veenstra K
1 reference
McDermott DF
1 reference
Clancy D
1 reference
Clancy M
1 reference
Atkins MB
1 reference
1 May 2000
1 reference
1 reference
1678-1692
1 reference